Tumor location and type affect local recurrence and joint damage in tenosynovial giant cell tumor: a multi-center study

被引:11
|
作者
Ota, Takehiro [1 ,5 ]
Nishida, Yoshihiro [1 ,2 ]
Ikuta, Kunihiro [1 ]
Tsukushi, Satoshi [3 ]
Yamada, Kenji [4 ]
Kozawa, Eiji [5 ]
Urakawa, Hiroshi [1 ]
Imagama, Shiro [1 ]
机构
[1] Nagoya Univ, Dept Orthopaed Surg, Grad Sch Med, Nagoya, Aichi, Japan
[2] Nagoya Univ Hosp, Dept Rehabil Med, Showa Ku, 65 Tsurumai, Nagoya, Aichi 4668550, Japan
[3] Aichi Canc Ctr Hosp, Dept Orthopaed Surg, Nagoya, Aichi, Japan
[4] Okazaki City Hosp, Dept Orthopaed Surg, Okazaki, Aichi, Japan
[5] Nagoya Mem Hosp, Dept Orthopaed Surg, Nagoya, Aichi, Japan
关键词
PIGMENTED VILLONODULAR SYNOVITIS; ARTHROSCOPIC TREATMENT; TENDON SHEATH; FOLLOW-UP; KNEE; SYNOVECTOMY; OUTCOMES; FOOT; EXPRESSION; ANKLE;
D O I
10.1038/s41598-021-96795-6
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Osteochondral destruction and a high recurrence rate after surgery are major concerns that make difficult the treatment course of tenosynovial giant cell tumor. The aims of this study were to elucidate rates of postoperative local recurrence and osteochondral destruction, as correlated with various demographic factors. Eighty surgically treated patients with intra-articular tumors (knee: 49, ankle and foot: 12, hip: 10, others: 9) were included in this study. Factors including age, disease type (diffuse/localized), location, existence of osteochondral destruction were correlated with local recurrence or development/progression of osteochondral destruction. The 5-year local recurrence free survival rate was 71.4%. Diffuse type (n = 59, localized: n = 21) (P = 0.023) and knee location (P = 0.002) were independent risk factors for local recurrence. Diffuse type (P = 0.009) was a significant risk factor, and knee location (P = 0.001) was a negative factor for osteochondral destruction at the initial examination. Progression of osteochondral destruction was observed more often in cases with local recurrence (P = 0.040) and findings of osteochondral destruction at the initial examination (P = 0.029). Diffuse type is a factor that should be noted for both local recurrence and osteochondral destruction, while local recurrence occurs but osteochondral destruction is less observed in the knee.
引用
收藏
页数:10
相关论文
共 50 条
  • [31] Treatment, recurrence rates and follow-up of Tenosynovial Giant Cell Tumor (TGCT) of the foot and ankle-A systematic review and meta-analysis
    Siegel, M.
    Bode, L.
    Suedkamp, N.
    Kuehle, J.
    Zwingmann, J.
    Schmal, H.
    Herget, G. W.
    PLOS ONE, 2021, 16 (12):
  • [32] Diffuse-Type Tenosynovial Giant Cell Tumor: What Are the Important Findings on the Initial and Follow-Up MRI?
    Choi, Woo Suk
    Lee, Seul Ki
    Kim, Jee-Young
    Kim, Yuri
    Niendorf, Thoralf
    CANCERS, 2024, 16 (02)
  • [33] Arthroscopic Verses Open Management of Diffuse-Type Tenosynovial Giant Cell Tumor of the Knee: A Meta-analysis of Retrospective Cohort Studies
    Chandra, Akhil A.
    Agarwal, Shreya
    Donahue, Ahna
    Handorf, Elizabeth
    Abraham, John A.
    JOURNAL OF THE AMERICAN ACADEMY OF ORTHOPAEDIC SURGEONS GLOBAL RESEARCH AND REVIEWS, 2021, 4 (12):
  • [34] Diffuse-Type Tenosynovial Giant Cell Tumor of the Thoracic Spine Appearance on FDG PET/CT
    Shen, Guohua
    Ma, Huan
    Pan, Lili
    Su, Minggang
    Kuang, Anren
    CLINICAL NUCLEAR MEDICINE, 2019, 44 (08) : E477 - E478
  • [35] Single-Cell Analysis Clarifies Pathological Heterogeneity in Tenosynovial Giant Cell Tumor and Identifies Biomarkers for Predicting Disease Recurrence
    Xie, Yubin
    Chen, Chen
    Wu, Fei
    Peng, Yiman
    Su, Jing
    Zhao, Yang
    Huang, Hongjie
    Li, Zhong Alan
    Pei, Yin
    Li, Wencui
    He, Yi
    Xue, Tianchen
    Cao, Chenxi
    Peng, Sui
    Zhang, Xin
    Song, Weidong
    ADVANCED SCIENCE, 2025,
  • [36] Diffuse tenosynovial giant cell tumor in the temporomandibular joint area in a Chinese population: a clinicopathological analysis of 32 cases
    Zhang, Chunye
    Zhu, Ling
    Wang, Lizhen
    Hu, Yuhua
    Li, Jiang
    Tian, Zhen
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2016, 9 (02): : 1105 - 1115
  • [37] Pigmented villonodular synovitis/diffuse-type tenosynovial giant cell tumor: Opening options in management
    Eberst, L.
    Brahmi, M.
    Blay, J. -Y.
    Cassier, P. A.
    DRUGS OF THE FUTURE, 2017, 42 (02) : 105 - 111
  • [38] Giant cell tumor of temporomandibular joint presenting as a parotid tumor: Challenges in the accurate subclassification of giant cell tumors in an unusual location
    Ren, Rongqin
    Mueller, Sandra
    Kraft, Adele O.
    Powers, Celeste N.
    DIAGNOSTIC CYTOPATHOLOGY, 2018, 46 (04) : 340 - 344
  • [39] Diffuse-type Tenosynovial Giant Cell Tumor Invading the Temporal Bone: Three Cases
    Huang, Qilin
    Wu, Xia
    Xia, Qin
    Xie, Zhen
    Xiao, Hongjun
    Sun, Yu
    Jia, Yulin
    Yao, Dongxiao
    Guang, Xuan
    Cheng, Huamao
    ENT-EAR NOSE & THROAT JOURNAL, 2022,
  • [40] Diffuse Tenosynovial Giant Cell Tumor Around the Temporomandibular Joint: An Entity With Special Radiologic and Pathologic Features
    Wang, Ji-Gang
    Liu, Jingwei
    He, Bing
    Gao, Ling
    Zhang, Lijuan
    Liu, Jihua
    JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY, 2019, 77 (05) : 1022.e1 - 1022.e39